Expression and function of Toll-like receptor 9 in severely injured patients prone to sepsis

Clinical and Experimental Immunology

Volumn 145, Issue 3, 2006, Pages 456-462

  Baiyee, E E ^a   Flohe, S ^a   Lendemans, S ^a   Bauer, S ^b   Mueller, N ^a   Kreuzfelder, E ^a   Grosse Wilde, H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Inst Med Mikrobiol Immunol H   (Germany)

Author keywords

B cells; CpG; Sepsis; TLR9; Trauma

Indexed keywords

BACTERIAL DNA; HLA DR ANTIGEN; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ADULT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL PROLIFERATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INJURY; INJURY SCALE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS;

ADULT; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CPG ISLANDS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSION; INJURY SEVERITY SCORE; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MULTIPLE TRAUMA; PROSPECTIVE STUDIES; SEPSIS; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 9; WOUND INFECTION;

EID: 33747408269     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03160.x     Document Type: Article

References (28)

1. Sauaia A, Moore FA, Moore EE et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38:185-93.
2. Regel G, Lobenhoffer P, Grotz M, Pape HC, Lehmann U, Tscherne H. Treatment results of patients with multiple trauma: an analysis of 3406 cases treated between 1972 and 1991 as a German level I trauma center. J Trauma 1995; 38:70-8.
3. Hershman MJ, Cheadle WG, Kuftinee D, Polk Jr. HC. An outcome predictive score for sepsis and death following injury. Injury 1988; 19:263-6.
4. Döcke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat Med 1997; 3:678-81.
5. Ditschkowski M, Kreuzfelder E, Rebmann V et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229:246-54.
6. Ditschkowski M, Kreuzfelder E, Majetschak M, Obertacke U, Schade UF, Grosse-Wilde H. Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury. Eur J Surg 1999; 165:1129-33.
7. Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5:190-8.
8. Akira S. Toll receptor families: structure and function. Semin Immunol 2004; 16:1-2.
9. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.
10. Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98:9237-42.
11. Vinuesa CG, Goodnow CC. Immunology: DNA drives autoimmunity. Nature 2002; 416:595-8.
12. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MI, Marshak-Rothstein A. Chromatin-IgG comoplexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416:603-7.
13. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes. inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003; 102:956-63.
14. Dasari P, Nicholson IC, Hodge G, Dandie GW, Zola H. Expression of toll-like receptors on B lymphocytes. Cell Immunol 2005; 236:140-5.
15. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14:187-96.
16. Trupka A, Waydhas C, Nast-Kolb D, Schweiberer L. Early intubation in severely injured patients. Eur J Em Med 1994; 1:1-8.
17. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Am College Chest Physicians/Soc Crit Care Med Chest 1992; 101:1644-55.
18. Mueller A, Kreuzfelder E, Nyadu B et al. Human leucocyte antigen-DR expression in peripheral blood mononuclear cells from healthy donors influenced by the sera of injured patients prone to severe sepsis. Int Care Med 2003; 29:2285-90.
19. Bauer M, Heeg K, Wagner H, Lipford GB. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology 1999; 97:699-705.
20. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004; 25:381-5.
21. Eaton-Bassiri A, Dillon SB, Cunningham M et al. Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immun 2004; 72:7202-11.
22. Saikh KU, Kissner TL, Sultana A, Ruthel G, Ulrich RG. Human monocytes infected with Yersinia pestis express surface TLR9 and differentiate into dendritic cells. J Immunol 2004; 173:7426-34.
23. Adib-Conquy M, Moine P, Asehnoune K et al. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med 2003; 168:158-64.
24. Flohe S, Lendemans S, Selbach C et al. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 2003; 31:2462-9.
25. Majetschak M, Flach R, Heukamp T et al. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J Trauma 1997; 43:880-7.
26. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7:131-7.
27. Lo YMD, Rainer TH, Chan LYS, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46:319-23.
28. Cooper CL, Davis HL, Morris ML et al. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol 2004; 24:693-701.